Peninsula biotech company looks to pump new life into heart disease treatments


The company, based on the Peninsula and with manufacturing in the East Bay, has key milestones emerging in this year's final quarter.

Previous Athersys makes a deal to license its stem-cell technologies for animals
Next How this physician group plans to add behavioral health to all of its primary care clinics